0.6252

6.69% -0.0448

After Hours: .63 0.0048 +0.77%

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $0.6252, with a volume of 202.54K. It is down -6.69% in the last 24 hours and down -21.16% over the past month. Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Previous Close:

$0.67

Open:

$0.68

24h Volume:

202.54K

Relative Volume:

0.60

Market Cap:

$93.59M

Revenue:

$49.09M

Net Income/Loss:

$-52.15M

P/E Ratio:

-0.9618

EPS:

-0.65

Net Cash Flow:

$-45.93M

1W Performance:

-24.72%

1M Performance:

-21.16%

6M Performance:

-64.88%

1Y Performance:

-56.28%

1-Day Range:

$0.6252

$0.70

1-Week Range:

$0.6252

$0.85

52-Week Range:

$0.6252

$2.04

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1164)

Industry

Diagnostics & Research (59)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

273

Twitter

Next Earnings Date

2025-03-03

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	0.6252	93.59M	49.09M	-52.15M	-45.93M	-0.65
TMO Thermo Fisher Scientific Inc	497.60	196.14B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	205.00	150.17B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	419.95	34.36B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	116.98	33.45B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	176.30	31.62B	15.41B	1.37B	2.11B	7.50

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

07:27 AM

Biodesix, Inc. (NASDAQ:BDSX) Shares Acquired by AIGH Capital Management LLC - MarketBeat

07:27 AM

Mar 28, 2025

Perkins Capital Management Inc. Purchases 335,429 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat

Mar 28, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 28, 2025

Mar 20, 2025

Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat

Mar 20, 2025

Mar 17, 2025

Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier - Business Wire

Mar 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in February - Defense World

Mar 17, 2025

Biodesix to Present at Cowen’s 42nd Annual Healthcare Conference - Business Wire

Mar 17, 2025

Mar 16, 2025

Biodesix at TD Cowen Conference: Transformative Year Ahead By Investing.com - Investing.com UK

Mar 06, 2025

Biodesix at TD Cowen Conference: Transformative Year Ahead - Investing.com

Mar 06, 2025

Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report - Yahoo Finance

Mar 06, 2025

William Blair Estimates Biodesix’s Q1 Earnings (NASDAQ:BDSX) - Defense World

Mar 06, 2025

Mar 05, 2025

It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - Simply Wall St

Mar 05, 2025

Biodesix (NASDAQ:BDSX) Receives “Outperform” Rating from William Blair - Defense World

Mar 05, 2025

Mar 04, 2025

Biodesix, Inc. Reports Strong Growth Amid Financial Challenges - TipRanks

Mar 04, 2025

Positive Outlook for Biodesix: Buy Rating Supported by Salesforce Improvements and Revenue Growth Opportunities - TipRanks

Mar 04, 2025

Earnings call transcript: Biodesix Q4 2024 beats revenue expectations By Investing.com - Investing.com South Africa

Mar 04, 2025

Observations on the Biodesix Inc (NASDAQ:BDSX) Growth Curve - US Post News

Mar 04, 2025

Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN

Mar 04, 2025

Biodesix: Strong Growth and Promising Future with Buy Rating from Kyle Mikson CFA - TipRanks

Mar 04, 2025

US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says ExpertCrowdStrike Holdings (NASDAQ:CRWD), Biodesix (NASDAQ:BDSX) - Benzinga

Mar 04, 2025